Search Site

Investors

Quintiles helps to improve healthcare worldwide by providing a broad range of professional services, information and partnering solutions to the pharmaceutical services, biotechnology and healthcare industries.

With appreciation to our customers
for helping us be the best we can be.

Investor Relations

Learn more about Quintiles

NYSE: Q

$ 80.43

(COMMON STOCK)

Change (%): +1.37 +1.73%

Volume: 373,305

20 minute delay September 30, 2016

Quintiles is the world’s largest provider of biopharmaceutical development services and commercial outsourcing services. We are positioned at the intersection of business services and healthcare and generated $4.2 billion of service revenues in 2014, conduct business in approximately 100 countries and have more than 32,000 employees. We use the breadth and depth of our service offerings, our global footprint and our therapeutic, scientific and analytics expertise to help our biopharmaceutical customers, as well as other healthcare customers, navigate the increasingly complex healthcare environment to improve efficiency and to deliver better healthcare outcomes. Read More

Featured
Video

Reports & Presentations

Investor Tools

Print Page Email Page Share This Investor Tool Kit

Email Alerts

Email Address *
Mailing Lists *



 
Enter the code shown above.

Investor Relations Contact

Telephone: +1 919 998 2590
Quintiles Investor Relations
4820 Emperor Boulevard
PO Box 13979
Durham, North Carolina 27703